Oppenheimer Maintains Outperform on Acuity, Lowers Price Target to $415

Benzinga Newsdesk www.benzinga.com Negative 80.7%

Neg 80.7% Neu 0% Pos 0%

Oppenheimer analyst Christopher Glynn maintains Acuity (NYSE:AYI) with a Outperform and lowers the price target from $440 to $415.